SRF Share Price Target 2026, 2027, 2028, 2029, 2030
- Market Cap
- ₹78,637 Cr
- Book Value
- ₹474
- Stock P/E
- 35.1
- Dividend Yield
- 0.34%
- ROE
- 14.3%
- ROCE
- 14.6%
- PEG Ratio
- 3.62
- EV/EBITDA
- 21.2
Fundamentals from Screener.in, as of 5 Aug 2026. Live price via Yahoo Finance.
SRF share price today
SRF (NSE: SRF) is India’s fluorochemicals heavyweight — refrigerant gases where regulation-driven scarcity sets prices, and specialty agro/pharma intermediates where its chemistry bench competes globally — bolted to a packaging-films business that is deep in commodity oversupply and a legacy technical-textiles arm. The blend means SRF’s earnings breathe with two cycles at once, and right now both inhale: TTM profits are below trend, and the universe flags exactly that.
Our tag is wait, with conviction about the destination: the chemistry moat — plants, patents, fluorination competence — outlasts every trough. At 35.1× on depressed earnings, the multiple is optically high because the E is cyclically low.
Two engines, one trough
Fluorochemicals: HFC phase-down quotas turn refrigerants into a licensed oligopoly — pricing spikes as quotas bite — while next-gen gas and PTFE-adjacent investments extend the franchise. Specialty chemicals: multi-step fluorinated intermediates for global agrochem innovators, a business that tripled through the last upcycle and is now digesting customer destocking. Packaging films will stay commodity — the question is only how much it dilutes the chemistry story while capacity digests.
Watch-items: agrochem-customer restocking (the cycle-turn signal), refrigerant quota pricing, films spreads bottoming, and capex discipline (D/E 0.36 carries the build-out).
The numbers
From our research universe snapshot (5 Aug 2026):
| Metric | Value |
|---|---|
| Market cap | ₹78,637 Cr |
| P/E (TTM) | 35.1 |
| EV/EBITDA | 21.2 |
| Operating margin | 22.5% |
| ROE / ROCE | 14.3% / 14.6% |
| Debt to equity | 0.36 |
| Sales CAGR (5y) | 13.5% |
| Profit CAGR (5y) | 9.7% |
| Promoter holding | 50.3% |
| EPS (TTM) | ₹75.30 |
SRF share price target 2026 to 2030
EPS base ₹75.30 (TTM — cyclically depressed; scenarios embed recovery). Bear: the trough drags and films stay ugly — 7% growth, multiple at 22×. Base: agrochem restocks and refrigerants reprice — 14% growth at 30×. Bull: full chemistry upcycle — 20% growth at 38×.
| Year | Bear (22×, +7%) | Base (30×, +14%) | Bull (38×, +20%) |
|---|---|---|---|
| 2026 | ₹1,775 | ₹2,575 | ₹3,435 |
| 2027 | ₹1,895 | ₹2,935 | ₹4,120 |
| 2028 | ₹2,030 | ₹3,345 | ₹4,945 |
| 2029 | ₹2,170 | ₹3,815 | ₹5,935 |
| 2030 | ₹2,325 | ₹4,350 | ₹7,120 |
From ₹2,642, the base case is ≈ +65% over four and a half years; the bear is −12%. Cyclical franchises are bought in troughs or not at all — the range below is the trough, quantified.
Reasons to own SRF (at the right price)
- Fluorination competence — the same scarce-chemistry moat as the specialty leaders, at industrial scale.
- Refrigerant quotas are regulation-manufactured pricing power.
- Specialty intermediates relationships with global agro innovators survive destocking.
- The cycle is the discount: trough earnings, trough sentiment, intact assets.
- A 50.3% promoter with a multi-decade record of reinvesting through cycles.
The risks: this trough has run longer than most expected, films may dilute returns for years, and ROCE at 14.6% must recover to justify the franchise premium.
Should you buy at the current price?
The live buy range below is for members — where the cycle’s patience test pays best.
FAQ
What is the SRF share price target for 2030? Base case ≈ ₹4,350 (30× on 14% compounded growth), bear ≈ ₹2,325, bull ≈ ₹7,120. Arithmetic above.
Why are SRF’s recent numbers weak? Global agrochem customers over-ordered in 2021–23 and have been destocking since, while packaging-films capacity gluts compressed spreads. Both are cyclical, neither is structural.
What are refrigerant quotas? International HFC phase-down agreements cap production via licences. Scarcity is written into law — quota holders like SRF gain pricing power as caps tighten.
When are SRF’s next results? Track the exact date on our results calendar.
This article is research and education, not personalised investment advice. We are not SEBI-registered advisers. Price targets are scenario arithmetic, not promises. Do your own research and consult a registered adviser before acting.